{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:19:59Z","timestamp":1790698799232,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"Supplement_5","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1184344"],"award-info":[{"award-number":["OPP1184344"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The low prevalence levels associated with lymphatic filariasis elimination pose a challenge for effective disease surveillance. As more countries achieve the World Health Organization criteria for halting mass treatment and move on to surveillance, there is increasing reliance on the utility of transmission assessment surveys (TAS) to measure success. However, the long-term disease outcomes after passing TAS are largely untested. Using 3 well-established mathematical models, we show that low-level prevalence can be maintained for a long period after halting mass treatment and that true elimination (0% prevalence) is usually slow to achieve. The risk of resurgence after achieving current targets is low and is hard to predict using just current prevalence. Although resurgence is often quick (&amp;lt;5 years), it can still occur outside of the currently recommended postintervention surveillance period of 4\u20136 years. Our results highlight the need for ongoing and enhanced postintervention monitoring, beyond the scope of TAS, to ensure sustained success.<\/jats:p>","DOI":"10.1093\/infdis\/jiz647","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T20:09:55Z","timestamp":1575576595000},"page":"S503-S509","source":"Crossref","is-referenced-by-count":24,"title":["Elimination or Resurgence: Modelling Lymphatic Filariasis After Reaching the 1% Microfilaremia Prevalence Threshold"],"prefix":"10.1093","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4699-5931","authenticated-orcid":false,"given":"Joaquin M","family":"Prada","sequence":"first","affiliation":[{"name":"School of Veterinary Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L","family":"Davis","sequence":"first","affiliation":[{"name":"Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research, Mathematics Institute and School of Life Sciences, University of Warwick, Coventry, UK"},{"name":"Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Headington, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiota","family":"Touloupou","sequence":"first","affiliation":[{"name":"Department of Statistics, University of Warwick, Coventry, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma A","family":"Stolk","sequence":"first","affiliation":[{"name":"Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Periklis","family":"Kontoroupis","sequence":"first","affiliation":[{"name":"Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, University of Notre Dame, South Bend, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarnali","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, University of Notre Dame, South Bend, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Michael","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, University of Notre Dame, South Bend, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sake J","family":"de Vlas","sequence":"first","affiliation":[{"name":"Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T D\u00e9irdre","family":"Hollingsworth","sequence":"first","affiliation":[{"name":"Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Headington, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"2020061115544645000_CIT0001","first-page":"1","article-title":"Recommendations of the international task force for disease eradication","volume":"42","author":"Center for Disease Control","year":"1993","journal-title":"Morb Mortal Wkly Rep"},{"key":"2020061115544645000_CIT0002","first-page":"489","article-title":"Global programme to eliminate lymphatic filariasis: progress report, 2014","volume":"38","author":"World Health Organization","year":"2015","journal-title":"WHO Wkly Epidemiol Rec"},{"key":"2020061115544645000_CIT0003","volume-title":"Lymphatic filariasis: monitoring and epidemiological assessment of mass drug administration, a manual for national elimination programmes.","author":"World Health Organization (WHO)","year":"2011"},{"key":"2020061115544645000_CIT0004","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/2049-9957-2-30","article-title":"The history of the elimination of lymphatic filariasis in China","volume":"2","author":"De-Jian","year":"2013","journal-title":"Infect Dis Poverty"},{"key":"2020061115544645000_CIT0005","first-page":"589","article-title":"Global programme to eliminate lymphatic filariasis: progress report, 2017","volume":"93","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"2020061115544645000_CIT0006","doi-asserted-by":"crossref","first-page":"e0005280","DOI":"10.1371\/journal.pntd.0005280","article-title":"Fifteen years of programme implementation for the elimination of lymphatic filariasis in Ghana: impact of MDA on immunoparasitological indicators","volume":"11","author":"Biritwum","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2020061115544645000_CIT0007","doi-asserted-by":"crossref","first-page":"e3281","DOI":"10.1371\/journal.pntd.0003281","article-title":"A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration","volume":"8","author":"Rao","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2020061115544645000_CIT0008","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1473-3099(16)30467-4","article-title":"Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study","volume":"17","author":"Irvine","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2020061115544645000_CIT0009","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1017\/S0950268899003702","article-title":"EPIFIL: The development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis","volume":"124","author":"Norman","year":"2000","journal-title":"Epidemiol Infect"},{"key":"2020061115544645000_CIT0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(04)00973-9","article-title":"Mathematical modelling and the control of lymphatic filariasis","volume":"4","author":"Michael","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"2020061115544645000_CIT0011","doi-asserted-by":"crossref","first-page":"e0006994","DOI":"10.1371\/journal.pntd.0006994","article-title":"Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana","volume":"13","author":"Minetti","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2020061115544645000_CIT0012","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/ciy003","article-title":"Are alternative strategies required to accelerate the global elimination of lymphatic filariasis? Insights from mathematical models","volume":"66","author":"Stolk","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2020061115544645000_CIT0013","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.epidem.2017.02.006","article-title":"Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework","volume":"18","author":"Smith","year":"2017","journal-title":"Epidemics"},{"key":"2020061115544645000_CIT0014","volume-title":"Infectious diseases of humans: dynamics and control","author":"Anderson","year":"1992"},{"key":"2020061115544645000_CIT0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1741-7007-8-22","article-title":"Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis","volume":"8","author":"Gambhir","year":"2010","journal-title":"BMC Biol"},{"key":"2020061115544645000_CIT0016","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1186\/s13071-015-1152-3","article-title":"Modelling strategies to break transmission of lymphatic filariasis\u2013aggregation, adherence and vector competence greatly alter elimination","volume":"8","author":"Irvine","year":"2015","journal-title":"Parasit Vectors"},{"key":"2020061115544645000_CIT0017","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12916-016-0557-y","article-title":"Heterogeneous dynamics, robustness\/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis","volume":"14","author":"Michael","year":"2016","journal-title":"BMC Med"},{"key":"2020061115544645000_CIT0018","doi-asserted-by":"crossref","first-page":"e2874","DOI":"10.1371\/journal.pone.0002874","article-title":"Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis","volume":"3","author":"Gambhir","year":"2008","journal-title":"PLoS One"},{"key":"2020061115544645000_CIT0019","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.pt.2019.08.003","article-title":"Evaluating the evidence for lymphatic filariasis elimination","volume":"35","author":"Davis","year":"2019","journal-title":"Trends Parasitol"},{"key":"2020061115544645000_CIT0020","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s13071-015-1132-7","article-title":"Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, lymphatic filariasis","volume":"8","author":"Singh","year":"2015","journal-title":"Parasit Vectors"},{"key":"2020061115544645000_CIT0021","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0038-1634505","article-title":"The LYMFASIM simulation program for modeling lymphatic filariasis and its control","volume":"37","author":"Plaisier","year":"1998","journal-title":"Methods Inf Med"},{"key":"2020061115544645000_CIT0022","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1017\/S0031182008000437","article-title":"LYMFASIM, a simulation model for predicting the impact of lymphatic filariasis control: quantification for African villages","volume":"135","author":"Stolk","year":"2008","journal-title":"Parasitology"},{"key":"2020061115544645000_CIT0023","doi-asserted-by":"crossref","first-page":"e0005206","DOI":"10.1371\/journal.pntd.0005206","article-title":"Making transmission models accessible to end-users: the example of TRANSFIL","volume":"11","author":"Irvine","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2020061115544645000_CIT0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.epidem.2017.02.002","article-title":"Measuring and modelling the effects of systematic non-adherence to mass drug administration","volume":"18","author":"Dyson","year":"2017","journal-title":"Epidemics"},{"key":"2020061115544645000_CIT0025","volume-title":"Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis","author":"World Health Organization (WHO)","year":"2017"},{"key":"2020061115544645000_CIT0026","doi-asserted-by":"crossref","first-page":"e67004","DOI":"10.1371\/journal.pone.0067004","article-title":"Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS One"},{"key":"2020061115544645000_CIT0027","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s13071-017-2256-8","article-title":"Identifying optimal threshold statistics for elimination of hookworm using a stochastic simulation model","volume":"10","author":"Truscott","year":"2017","journal-title":"Parasit Vectors"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiz647\/31565080\/jiz647.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/221\/Supplement_5\/S503\/33379576\/jiz647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/221\/Supplement_5\/S503\/33379576\/jiz647.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T21:09:45Z","timestamp":1591909785000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/221\/Supplement_5\/S503\/5680710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":27,"journal-issue":{"issue":"Supplement_5","published-online":{"date-parts":[[2019,12,19]]},"published-print":{"date-parts":[[2020,6,11]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz647","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6,15]]},"published":{"date-parts":[[2019,12,19]]}}}